OTCMKTS:SARTF - Sartorius Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $134.2782 +24.78 (+22.63 %) (As of 02/15/2019 04:00 PM ET)Previous Close$109.5026Today's Range$134.2782 - $134.278252-Week Range$109.5026 - $149.00Volume500 shsAverage VolumeN/AMarket Capitalization$5.03 billionP/E RatioN/ADividend YieldN/ABeta0.07 ProfileDiscussionAnalyst RatingsChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email There is no company description available for Sartorius AG. Receive SARTF News and Ratings via Email Sign-up to receive the latest news and ratings for SARTF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Dental equipment & supplies Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:SARTF Previous SymbolNASDAQ:SARTF CUSIPN/A Webwww.sartorius.com Phone49-55-130-80Debt Debt-to-Equity Ratio1.08 Current Ratio1.62 Quick Ratio1.00Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.59 billion Price / Sales3.17 Cash Flow$7.7797 per share Price / Cash Flow17.26 Book Value$24.35 per share Price / Book5.51Profitability EPS (Most Recent Fiscal Year)N/A Net Income$129.67 million Net Margins9.09% Return on Equity20.21% Return on Assets7.10%Miscellaneous Employees7,501 Outstanding Shares37,440,000Market Cap$5.03 billion OptionableNot Optionable Sartorius (OTCMKTS:SARTF) Frequently Asked Questions What is Sartorius' stock symbol? Sartorius trades on the OTCMKTS under the ticker symbol "SARTF." When is Sartorius' next earnings date? Sartorius is scheduled to release their next quarterly earnings announcement on Tuesday, February 19th 2019. View Earnings Estimates for Sartorius. What is the consensus analysts' recommendation for Sartorius? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Sartorius. Has Sartorius been receiving favorable news coverage? News stories about SARTF stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Sartorius earned a daily sentiment score of 1.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. Who are some of Sartorius' key competitors? Some companies that are related to Sartorius include Straumann (SAUHF), DENTSPLY SIRONA (XRAY), Nobel Biocare (NBHGF), BIOLASE (BIOL), Biomerica (BMRA) and Remedent (REMI). How do I buy shares of Sartorius? Shares of SARTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Sartorius' stock price today? One share of SARTF stock can currently be purchased for approximately $134.2782. How big of a company is Sartorius? Sartorius has a market capitalization of $5.03 billion and generates $1.59 billion in revenue each year. Sartorius employs 7,501 workers across the globe. What is Sartorius' official website? The official website for Sartorius is http://www.sartorius.com. How can I contact Sartorius? Sartorius' mailing address is OTTO-BRENNER-STRASSE 20, GOETTINGEN 2M, 37079. The company can be reached via phone at 49-55-130-80 or via email at [email protected] MarketBeat Community Rating for Sartorius (OTCMKTS SARTF)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 93 (Vote Outperform)Underperform Votes: 101 (Vote Underperform)Total Votes: 194MarketBeat's community ratings are surveys of what our community members think about Sartorius and other stocks. Vote "Outperform" if you believe SARTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SARTF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/15/2019 by MarketBeat.com StaffFeatured Article: What is the Book Value of a Share?